Percutaneous closure device for patent foramen ovale treatment in congenital heart disease, with clinical follow-up data documenting safety and efficacy.
Manufactured by
China
Beijing Balance Medical Technology Co., Ltd., established in 2005, specializes in animal-derived implantable medical devices. The company has 13 Class III medical device registrations and over 20 domestic and international invention patents. Listed on the Shanghai Stock Exchange STAR Market (688198) in 2019, the company focuses on three main areas: surgical soft tissue repair, heart valve replacement and repair, and congenital heart disease interventional treatment.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Rivarp Medical Pvt Ltd
India · 3 relevant products
Nanjing YDB Medical Technology Co., Ltd.
China · 1 relevant product
Xuzhou Henghui Braiding Machine Co.,Ltd
China · 2 relevant products
63 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →10 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 99 closest product alternatives
Rivarp Medical Pvt Ltd · India
An occluder device designed for the closure of patent ductus arteriosus (PDA) in cardiac patients. It is part of the Occlunix® occluders and delivery systems product line.
Nanjing YDB Medical Technology Co., Ltd. · China
Left atrial appendage occluder designed to prevent thromboembolic stroke in patients with atrial fibrillation. This interventional device provides mechanical closure of the left atrial appendage, eliminating the need for long-term anticoagulation therapy. The occluder is delivered via minimally invasive catheter-based approach for cardiac structural intervention.
Rivarp Medical Pvt Ltd · India
A septal occluder device designed for the percutaneous closure of ventricular septal defects (VSD) in the heart. It is part of the Occlunix® occluders and delivery systems product line for cardiac intervention.
96 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products